Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Effect of Oral Montelukast as Additional Treatment in the Management of Patients With Acute Severe Asthma.

NCT01011452 is registered in ClinicalTrials.gov with University of East Anglia as lead sponsor.

NCT NCT01011452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01011452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Effect of Oral Montelukast as Additional Treatment in the Management of Patients With Acute Severe Asthma.
Lead sponsor
University of East Anglia
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2001
Completion date
October 31, 2004
Enrollment
87 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute asthma exacerbation